| | 5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one|BGB-TG-P1 基本信息 更多信息 |
| 中文名称: | BGB-TG-P1 | | 中文同义词: | 苯并呋喃杂质3;RAF激酶和EGFR抑制剂(BGB-283);化合物:BGB-283;BGB-283 (Lifirafenib;BGB 283;BGB283);化合物:BGB-283;rel-5-(((1R,1aS,6bR)-1-(5-(三氟甲基)-1H-苯并[d]咪唑-2-基)-1a,6b-二氢-1H-环丙烷[b]苯并呋喃-5-基)氧基)-3,4-二氢-1,8-萘啶-2(1H)-酮 | | 英文名称: | 5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one | | 英文同义词: | 5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one;BGB-283;BGB-283,GDC-0810;BGB-TG-P1;bgb283(Lifirafenib);BGB-283;BGB 283;CS-2387;LIFIRAFENIB (BGB-283) | | CAS号: | 1446090-77-2 | | 分子式: | C25H17F3N4O3 | | 分子量: | 478.42 | | EINECS号: | | ![5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one|BGB-TG-P1](/CAS/20180629/GIF/1446090-77-2.gif) |
|
| 按国家浏览5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one国外供应商 |
中国供应商 |
|
5-(((1R,1aS,6bR)-1-(6-(trifluoromethyl)-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|